Abdul Mannan: Venous Thromboembolism Prophylaxis Is Often Overlooked in Medical Inpatients
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Venous thromboembolism remains a leading cause of preventable hospital deaths, yet prophylaxis is often overlooked in medical inpatients. Evidence shows that systematic risk assessment using tools like the Padua Score, combined with bleeding-risk stratification (IMPROVE), saves lives. Pharmacological prophylaxis with LMWH reduces VTE by up to 50% in at-risk patients, whilst mechanical methods offer alternatives when bleeding risk is high. As clinicians, we must embed VTE assessment into daily practice—document decisions, reassess regularly, and champion mechanical prophylaxis when pharmacological options are contraindicated. Let’s ensure every patient receives the right prophylaxis at the right time. Prevention is always better than treatment.”
Learn more here.
Stay updated on all scientific advances with Hemostasis Today.
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits